Digital Turbine, Inc. (NASDAQ:APPS) tinted loss of 0% (0 points) to US$1.45. The volume of 0.96 Million shares climbed down over an trading activity of 622.53 Million shares. EPS ratio determined by looking at last 12 month figures is -0.49. Over the same time span, the stock marked US$2.59 as its best level and the lowest price reached was US$1.01. The corporation has a market cap of US$108.9 Million.
Digital Turbine, Inc. (NASDAQ:APPS)’s earnings per share has been growing at a 7.3 percent rate over the past 5 year when average revenue increase was noted as 80.9 percent. The return on equity ratio or ROE stands at -102.7 percent while most common profitability ratio return on investment (ROI) was -65.3 percent. The company’s institutional ownership is monitored at 55.6 percent. The company’s net profit margin has achieved the current level of -70.7 percent and possesses 33.5 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 1.6. 3 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
Strongbridge Biopharma plc (NASDAQ:SBBP) is worth US$266.42 Million and has recently fallen 0% to US$5.7. The latest exchange of 0.4 Million shares is below its average trading activity of 354.99 Million shares. The day began at US$5.7 but the price moved to US$5.6 at one point during the trading and finally capitulating to a session high of US$5.8. The stock tapped a 52-week high of US$9.25 while the mean 12-month price target for the shares is US$13.67.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 142.5, and a price to sales ratio of 24.44. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown 0%. With an institutional ownership near 76%, it carries an earnings per share ratio of -2.97.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 3 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 3 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.5.